Management Board meeting: 11 March 2021
Date:
11/03/2021
Location:
European Medicines Agency, Amsterdam, the Netherlands
The Management Board is an integral governance body of the Agency. It has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director and the monitoring of the Agency's performance.
-
List item
Agenda for the 111th meeting of the Management Board (PDF/154.2 KB)
Draft
First published: 11/03/2021
Last updated: 12/03/2021
EMA/MB/34198/2021 -
List item
Minutes of the 111th meeting of the Management Board: 11 March 2021 (PDF/389.17 KB) (new)
Adopted
First published: 25/05/2021
EMA/MB/153834/2021 -
List item
Minor use or minor species (MUMS)/limited market scheme for veterinary medicinal products - 11th Annual Report (PDF/328.79 KB)
Adopted
First published: 12/03/2021
EMA/553359/2020 -
List item
2020 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission (PDF/876.14 KB)
First published: 12/03/2021
EMA/620104/2020 -
List item
2020 European Medicines Agency Annual Report on Independence (PDF/375.74 KB)
First published: 12/03/2021
EMA/34780/2021 -
List item
Big Data Steering Group (BDSG): 2020 report (PDF/528.47 KB)
First published: 12/03/2021
EMA/48625/2021 -
List item
European Medicines Agency's anti-fraud strategy - revised March 2021 (PDF/339.64 KB)
First published: 12/03/2021
EMA/128273/2021 -
List item
Outcome of written procedures finalised during the period from 26 November 2020 to 12 February 2021 (PDF/120.15 KB)
First published: 12/03/2021
EMA/MB/81947/2021 -
List item
Rules for the implementation of Council Regulation (EC) No 297/95 on fees payable to the European Medicines Agency and other measures - Revised implementing rules to the Fee Regulation as of 1 April 2021 (PDF/467.81 KB)
First published: 12/03/2021
EMA/MB/316533/2020 -
List item
Summary of transfers of appropriations in budgets 2020 and 2021 - Issues for consideration - Management Board meeting: 11 March 2021 (PDF/137.95 KB)
First published: 12/03/2021
EMA/MB/76157/2021